Abstract
The current study was designed to determine the effect of centrally administrated arachidonic acid (AA) on plasma gonadotropin hormone-releasing hormone (GnRH), follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone level, and sperm parameters, and to show the mediation of the central cyclooxygenase (COX) to thromboxane A2 (TXA2) signaling pathway in AA-induced hormonal and sperm parameter effects. Studies were performed in male Sprague-Dawley rats. A total of 150 or 300 μl/5 μl doses of AA were injected intracerebroventricularly (icv). AA significantly caused dose- and time-dependent increases in plasma FSH, LH and testosterone levels of animals, but not plasma GnRH level. AA also significantly increased sperm motility of the rats without change sperm number. Pretreated with ibuprofen, a nonselective COX inhibitor (250 μg/5 μl; icv), and furegrelate, a TXA2 synthesis inhibitor (250 μg/5 μl; icv), prevented AA-evoked increase in plasma FSH, LH and testosterone levels, and sperm motility. In conclusion, our findings show that centrally administered AA increases plasma FSH, LH and testosterone levels and sperm motility of conscious male rats. Moreover, according to our findings, central COX-TXA2 signaling p...Continue Reading
References
Oct 1, 1979·Prostaglandins·K Meeuwsen, R R Seeley
May 1, 1976·Endocrinology·J WarbergJ C Porter
Jun 1, 1976·Endocrinology·F M Badr
Jun 23, 1992·Biochemistry·H Dan-CohenZ Naor
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·L KieselB Runnebaum
Sep 1, 1991·Molecular and Cellular Endocrinology·Z Naor
May 1, 1989·Neuroendocrinology·T NishizakiO Tanizawa
Jan 1, 1989·Life Sciences·J R Cashman
Dec 1, 1986·Endocrinology·A Negro-VilarM Valenca
Jan 1, 1987·Progress in Lipid Research·J TurkM L McDaniel
Jan 1, 1988·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S A Metz
Aug 24, 1973·Science·P G HarmsS M McCann
Apr 1, 1973·Prostaglandins·A TsafririH R Lindner
Mar 10, 1974·Prostaglandins·T SatoM Igarashi
Nov 1, 1982·Endocrinology·I J Clarke, J T Cummins
Nov 1, 1994·Biochemistry·D Ben-MenahemZ Naor
Mar 1, 1995·Cellular Signalling·W A KhanY A Hannun
Nov 1, 1993·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A R Priddy, S R Killick
Jan 1, 1996·The Journal of Endocrinology·H IkawaT Aono
Dec 31, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M B HerreroM A Gimeno
Dec 24, 1997·Human Reproduction·R W Kelly, H O Critchley
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·John K Amory, William J Bremner
Mar 6, 2004·Pharmacology·Murat Yalcin, Vahide Savci
Apr 13, 2005·Theriogenology·Mustafa SönmezAbdurrauf Yüce
Aug 16, 2005·Journal of Chemical Neuroanatomy·Ken W S Ashwell, George Paxinos
Apr 4, 2007·Journal of Neurochemistry·Francesca Bosetti
Jun 24, 2008·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Cenk Aydin, Murat Yalcin
Aug 26, 2009·Clinical and Experimental Pharmacology & Physiology·Murat Yalcin, Cenk Aydin
Feb 18, 2011·Canadian Journal of Physiology and Pharmacology·Murat Yalcin
Jun 11, 2011·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Murat Yalcin, Cenk Aydin
Jan 11, 2012·Reproductive Toxicology·Juliana Elaine PerobelliWilma De Grava Kempinas
May 23, 2012·International Journal of Andrology·D M KristensenB Jégou